Comparing Prednisolone and Cerebrolysin for treating Bell's Palsy
Official title: Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy
Run by October 6 University · NCT05821075 · Data updated 2026-11-12
This study is testing whether Prednisolone or Cerebrolysin works better to help people with Bell's Palsy recover and avoid complications.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | October 6 University Academic / other |
| Locations | 1 site (Giza) |
| Status | Recruiting |
| Started | August 24, 2023 |
| Main results expected | January 2026 |
| Study ends | February 2026 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT05821075 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals experiencing unilateral acute facial palsy with no identifiable cause.
✕Probably not a fit
Patients with recurrent Bell's Palsy, certain medical conditions like diabetes or severe hypertension, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of two treatments, Prednisolone and Cerebrolysin, for patients suffering from Bell's Palsy, a condition characterized by sudden facial paralysis. The study aims to determine which of the two interventions provides better outcomes in terms of recovery and reduction of complications associated with the condition. Participants will be monitored for improvements in facial function and any adverse effects related to the treatments. The trial is designed to gather data from patients with acute unilateral facial palsy without identifiable causes.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients with Bell's Palsy, potentially improving recovery times and reducing complications.
How similar studies have gone: While corticosteroids are commonly used for Bell's Palsy, the use of Cerebrolysin is less established, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * unilateral acute facial palsy of no identifiable cause Exclusion Criteria: * Recurrent facial Bell's palsy * Pregnancy * Diabetes * Epilepsy * Severe hypertension, * Renal or hepatic disease, * Gastric or duodenal ulcer * presence of acute otitis media or ipsilateral chronic otitis * Recent head injury, * psychiatric disease * If there is any contraindications for corticosteroids
Where it's running
-
October 6 university hospital
Giza, Egypt Recruiting
Study contacts
- Study coordinator: Engy Wahsh
- Email: engywahsh@o6u.edu.eg
- Phone: 01003095692
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intradermal acupuncture and self-rehabilitation for severe Bell's Palsy
This study is testing if a combination of acupuncture and a self-rehabilitation program can help people with severe Bell's Palsy recover better than other treatments.
-
Exploring the link between facial paralysis and homocysteine levels
This study looks at whether higher levels of a substance in the blood called homocysteine are linked to Bell's palsy in adults who suddenly experience facial weakness or paralysis.
-
Laser acupuncture treatment for Bell's palsy
This study is testing if laser acupuncture can help people with Bell's palsy feel better compared to standard treatments and a fake treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.